Factors of Transference

SANDY, UTAH (the 1st of October, 2004) – In an announcement without precedents on marketing
of network, 4Life he informed today that the use of the products Transfer Factor of 4Life like
immune modulators it has been approved in hospitals and clinics of the Federation
Russian. The results of ten clinical essays and of two experimental studies
on the products Transfer Factor of 4Life they took shape of a document
methodological that was approved by the Department of Health, which now allows to
doctors to recommend the products Transfer Factor Classic and Transfer Factor Bonus ®
deLife to its patients.

PROFILE OF THE PRODUCT

The first nourishing complement approved by doctors and hospitals of Russia David
Lisonbee, DG of 4Life, on having commented on this notable achievement, showed: "To me
to know and to understand, this is the first time in the history of this industry that
a company of marketing of network or that a company of nourishing complements receives
the approval of the use of its nourishing complements in hospitals of Russia.
Department of Health of Russia is equivalent to the food Direction and
Medicines of the United States. The doctors and scientists of Russia they have
been working at joint form with the scientists of 4Life for several
years to reach this achievement. This approval fixes a new roll for
nourishing complements in the system of the care of the health of Russia.
Extraordinary answer of the Russian Academy of medical sciences

In another sector of investigation of Transfer Factor of 4Life, Dr. Kisielevsky
of the Russian academy of medical sciences (Russian Academy of Medical Sciences)
it showed: "The sample of 4Life [advanced formula of Transfer Factor] activated
the activity of the cells NK (lymphocytes citolíticos natural) more than
medicine Interleucina-2 (IL2) that we use in a standard way.” East
find has captivated the attention of the international technical and scientific Center
(ISTC – The International Scientific and Technical Center) of Russia.

Scientists' collaboration of diverse countries in additional clinical studies of
Transfer Factor The ISTC of Russia is part of an international project with others
obtain of health of Japan, Europe and the United States. The target of this project
international is to join efforts to discover better immunotherapies. After
finds of the tests of the lymphocytes citolíticos natural, the scientists
of 4Life they have been invited to join the project. In this international forum
it will keep on investigating Transfer Factor of 4Life like immune modulator.
cost of the studies will run in charge of the ISTC.

World consequences Dr. Calvin McCausland, Vice-president of Investigations
of 4Life, and Dr. Emma Oganova, the President of Eurasia of 4Life, on having spoken about
this reference achievement, they expressed jointly that due to the acceptance of
such a respected organization and of the doctors of Russia and of other countries
important, Transfer Factor of 4Life will reach a major acceptance in
sectors professional and deprived like a top product for the progress of
immune system. The world consequences of this acceptance newly are
beginning. 4Life he is the main world leader in development, production and
distribution of natural products of immune support and it was recently
recognized by the magazine Inc. as her 15th company of private ownership of more rapid
growth in the United States.

OPPRESS HERE TO CLARIFY SOME DOUBT OR TO ASK SOME QUESTION